Tony Huge

HCG With TRT: Keep Your Testicles, Fertility and Estrogen

Table of Contents

TL;DR

  • HCG mimics LH. On TRT your pituitary stops making LH, so HCG is what keeps your testes doing anything at all.
  • Compounded HCG became illegal to sell without a biologics license on 23 March 2020. Brand-name HCG (Pregnyl, Novarel) is still FDA-approved and still prescribable.
  • HCG raises estradiol too, because the same signal that drives testosterone also drives aromatase in the Leydig cell. Add HCG without checking labs and you can trade one imbalance for another.
  • 125 to 500 IU every other day is the dose range 2 real trials used.
  • I have run TRT for 14 years and used HCG inside that protocol. What follows is what I learned running it and what the trials found when they checked. Get your own labs before you set a dose.

The legal and prescription status, first

HCG is a prescription biologic, and the rules around it changed hard in 2020.

Human chorionic gonadotropin used to be something a compounding pharmacy could mix in-house under a doctor’s order. That ended on 23 March 2020, when the Biologics Price Competition and Innovation Act moved HCG, along with 3 other hormone products, off the exemptions that let compounding pharmacies make it. After that date, a compounding pharmacy needs a biologics license to legally produce HCG, and almost none have one. Outsourcing facilities that kept selling compounded HCG past that deadline were operating outside the law.

What survived is the brand-name, FDA-approved version. Pregnyl and Novarel are both still on the market in 2026, both require a prescription, and both are what a legitimate TRT clinic sends to a real pharmacy. If a source is offering compounded HCG at a discount with no clinic attached, ask what changed in 2020 to make that still legal. Nothing did.

What can go wrong before we get to what it fixes

HCG’s main side effect is the one people don’t expect: it raises estrogen.

The Leydig cell, the testicular cell that HCG stimulates, contains aromatase, the enzyme that converts testosterone into estradiol. Stimulate the Leydig cell and you don’t just get more testosterone, you get more of the raw material aromatase has to work with. In an isolated Leydig cell model, estradiol output rose within 30 minutes of HCG exposure, driven first by direct activation of the aromatase enzyme itself and then by the simple fact that there was more testosterone sitting there to convert. Add HCG to a TRT dose that is already aromatizing and you can push estradiol high enough to cause water retention, mood swings, or gynecomastia if nobody is watching the number.

The other real risks are more mundane. HCG is an injectable, so injection-site irritation is common. At higher or sustained doses some men report acne, mood changes tied to the estradiol swing above, and in rare cases gynecomastia that needs an aromatase inhibitor added to the stack to resolve. Order estradiol alongside total testosterone on every draw once HCG is in the protocol, starting with the first one.

The mechanism: why TRT needs a stand-in for LH at all

Exogenous testosterone works by flooding the bloodstream with the hormone your testes would otherwise make. Your pituitary reads that flood and does what it is built to do: it cuts luteinizing hormone, the signal that tells your testes to produce testosterone locally. No LH, no local signal, and the testes downshift. Volume drops. Sperm production drops with it, because intratesticular testosterone, not blood testosterone, is what drives spermatogenesis, and intratesticular levels run roughly 100 times higher than what a blood draw shows when the system is working normally.

This is my Law 1 in its cleanest form: governors versus accelerators. Exogenous testosterone is the accelerator, pure and simple, pressing blood testosterone up. The HPG axis shutdown is the governor, and it is not a bug, it is the body doing exactly what negative feedback is designed to do. Push the accelerator without touching the governor and you get high blood testosterone sitting on top of testicular tissue that has stopped receiving any signal to function. HCG is a molecular stand-in for the signal you shut off. It binds the same LH receptor on the Leydig cell that your own LH would have hit, so the testes keep getting told to make testosterone locally even while your pituitary has gone quiet. You are not boosting the system. You are refusing to let the governor win by default.

What the dosing trials found

One trial put healthy men on 200 mg of testosterone enanthate weekly and split them into 4 groups: placebo, 125 IU HCG every other day, 250 IU every other day, or 500 IU every other day. After 3 weeks, the 125 IU group’s intratesticular testosterone had dropped 25% from baseline. The 250 IU group dropped only 7%. The 500 IU group rose 26% above baseline. That data point is why 250 to 500 IU EOD became the range clinics use.

A separate group of 26 men on TRT ran 500 IU of HCG every other day for over a year. Their testosterone went from 207 to 1,055 ng/dL and their free testosterone roughly doubled. Their estradiol rose too, from 2.2 to 3.7 pg/mL, though that shift didn’t reach statistical separation in that small a sample. What mattered more: no one in the group developed abnormal semen parameters over the full follow-up.

A larger retrospective study looked at the opposite problem: 49 men who had already gone azoospermic or severely oligospermic on testosterone. Put on 3,000 IU of HCG subcutaneously every other day, often alongside clomiphene, tamoxifen, or an aromatase inhibitor, sperm production came back in an average of 4.6 months. That number matters if you’re the guy who started TRT without an HCG plan and only found out he had a fertility problem after his partner asked when they were trying to conceive.

Where the guidelines land

The American Urological Association’s testosterone deficiency guideline tells clinicians they may use HCG, an aromatase inhibitor, a SERM, or a combination in men who want to stay fertile on testosterone therapy. That is a conditional recommendation on Grade C evidence, which is guideline language for “reasonable, not proven at the highest tier.” HCG is the only one of those 3 options FDA-approved for use in men, which is part of why it’s the one most clinics reach for first.

My own experience with it

I have run TRT for 14 years and used HCG as part of that protocol. What I noticed lines up with what the trials found: the dose range that keeps things stable is narrower than most forum threads make it sound, and the estradiol side needs attention starting week 1. This is testimony about what I ran and noticed, one data point sitting next to the trials above. My labs, my dose history, and my response are mine. Yours will differ, and the only way to know where you land is to test.

Who this applies to

Men already on TRT who still want kids, or haven’t ruled it out. Men who noticed shrinkage after starting testosterone and want a reason their testes are still connected to the system. Men whose doctor mentioned HCG but didn’t explain the estradiol side of it. It is not for men chasing a bigger testosterone number for its own sake. HCG’s job on TRT is preservation, not enhancement.

The part most protocols skip

Most TRT clinics hand out a fixed HCG dose and never revisit it. That misses the individual variation sitting right in the trial data: 1 of the dosing groups in the intratesticular testosterone trial rose above baseline while a lower dose in the same trial still lost ground. Aromatase activity varies by body composition too, so a leaner man and a heavier man on the identical HCG dose can land at very different estradiol numbers. A fixed dose treats every testicle the same. The lab work is what corrects for the part genetics and body fat already decided before you drew up the syringe.

What to watch on bloodwork

Timeframe What to check
Week 4 to 6 Total and free testosterone, estradiol (sensitive assay), hematocrit
Week 8 to 12 Re-check estradiol after any dose change; testicular volume by self-exam or ultrasound if you started with atrophy
Month 6+ Semen analysis, the direct measure of whether fertility is preserved

Because HCG raises estradiol as a direct consequence of raising testosterone, some men add a low-dose aromatase inhibitor or a product that supports estrogen metabolism alongside it rather than treating the rise as a separate problem to solve later. I take an affiliate commission if you buy through some of the product links on this site, including Enhanced Labs, so take that into account when reading a recommendation. Black Ox is formulated with DIM specifically for the estrogen-control side of a testosterone protocol, which is the exact gap HCG opens.

Where the research still falls short

Nobody has run a large randomized trial testing HCG dose against fertility outcome as the primary endpoint. What exists is dose-finding studies with intratesticular testosterone as the marker, and retrospective case series on the recovery side. Real signal, not proof at the highest tier. If your family planning is on the line, that gap is a reason to test your own numbers rather than assume the group averages apply to you.

For the SERM alternative to HCG, including who should consider clomiphene or enclomiphene instead, read the full enclomiphene protocol. For what to run from day 1 of a cycle rather than waiting for a problem to show up, see Protection Starts on Day One. And if you’re still deciding whether TRT is the right call at all, the TRT vs natural testosterone breakdown covers that decision directly. For the full testosterone library, start at the testosterone hub.

References

  1. Coviello AD, Matsumoto AM, Bremner WJ, et al. Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression. J Clin Endocrinol Metab. 2005;90(5):2595-2602. PMID: 15713727. doi:10.1210/jc.2004-0802
  2. Hsieh TC, Pastuszak AW, Hwang K, Lipshultz LI. Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy. J Urol. 2013;189(2):647-650. PMID: 23260550. PubMed
  3. Wenker EP, Dupree JM, Langille GM, et al. The use of HCG-based combination therapy for recovery of spermatogenesis after testosterone use. J Sex Med. 2015;12(6):1334-1337. doi:10.1111/jsm.12890
  4. American Urological Association. Evaluation and Management of Testosterone Deficiency: AUA Guideline (2018, amended). auanet.org
  5. Valladares LE, Payne AH. Acute stimulation of aromatization in Leydig cells by human chorionic gonadotropin in vitro. Proc Natl Acad Sci USA. 1979;76(9):4460-4463. PMID: 291977. PubMed
  6. U.S. Food and Drug Administration / Biologics Price Competition and Innovation Act transition, effective 23 March 2020. Compounded human chorionic gonadotropin no longer eligible for Section 503A/503B exemptions. PCCA compounding update